메뉴 건너뛰기




Volumn 3, Issue 6, 2010, Pages 339-350

Quetiapine in the treatment of psychosis in Parkinson’s disease

Author keywords

antipsychotics; Parkinson s disease; psychosis; quetiapine

Indexed keywords

AMANTADINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; LEVODOPA; PLACEBO; QUETIAPINE; SELEGILINE;

EID: 78649948342     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285610389656     Document Type: Review
Times cited : (51)

References (52)
  • 1
    • 0032916601 scopus 로고    scopus 로고
    • Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study
    • Aarsland, D., Larsen, J.P., Cummins, J.L. and Laake, K. ( 1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56: 595-601.
    • (1999) Arch Neurol , vol.56 , pp. 595-601
    • Aarsland, D.1    Larsen, J.P.2    Cummins, J.L.3    Laake, K.4
  • 2
    • 0035000813 scopus 로고    scopus 로고
    • A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia
    • Aarsland, D., Ballard, C., Larsen, J.P. and McKeith, I. ( 2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 16: 528-536.
    • (2001) Int J Geriatr Psychiatry , vol.16 , pp. 528-536
    • Aarsland, D.1    Ballard, C.2    Larsen, J.P.3    McKeith, I.4
  • 3
    • 0033895282 scopus 로고    scopus 로고
    • Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study
    • Aarsland, D., Larsen, J.P., Tandberg, E. and Laake, K. ( 2000) Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 48: 938-942.
    • (2000) J Am Geriatr Soc , vol.48 , pp. 938-942
    • Aarsland, D.1    Larsen, J.P.2    Tandberg, E.3    Laake, K.4
  • 4
    • 0030795988 scopus 로고    scopus 로고
    • Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group
    • Arvanitis, L.A. and Miller, B.G. ( 1997) Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 42: 233-246.
    • (1997) Biol Psychiatry , vol.42 , pp. 233-246
    • Arvanitis, L.A.1    Miller, B.G.2
  • 5
    • 0037253385 scopus 로고    scopus 로고
    • Reality monitoring and visual hallucinations in Parkinson's disease
    • Barnes, J., Boubert, L., Harris, J., Lee, A. and David, A.S. ( 2003) Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia 41: 565-574.
    • (2003) Neuropsychologia , vol.41 , pp. 565-574
    • Barnes, J.1    Boubert, L.2    Harris, J.3    Lee, A.4    David, A.S.5
  • 6
    • 0034990077 scopus 로고    scopus 로고
    • Visual hallucinations in Parkinson's disease: a review and phenomenological survey
    • Barnes, J. and David, A.S. ( 2001) Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 70: 727-733.
    • (2001) J Neurol Neurosurg Psychiatry , vol.70 , pp. 727-733
    • Barnes, J.1    David, A.S.2
  • 7
    • 0029878084 scopus 로고    scopus 로고
    • ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group
    • Borison, R.L., Arvanitis, L.A. and Miller, B.G. ( 1996) ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group. J Clin Psychopharmacol 16: 158-169.
    • (1996) J Clin Psychopharmacol , vol.16 , pp. 158-169
    • Borison, R.L.1    Arvanitis, L.A.2    Miller, B.G.3
  • 8
    • 0037039263 scopus 로고    scopus 로고
    • Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease
    • Brandstadter, D. and Oertel, W.H. ( 2002) Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 58: 160-161.
    • (2002) Neurology , vol.58 , pp. 160-161
    • Brandstadter, D.1    Oertel, W.H.2
  • 9
    • 84993716813 scopus 로고    scopus 로고
    • Atypical antipsychotic drugs and stroke
    • Committee on Safety of Medicines 9 March 2004. Available at (accessed 26 April 2010)
    • Committee on Safety of Medicines (2004) Atypical antipsychotic drugs and stroke. Latest news, 9 March 2004. Available at: https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=100974 (accessed 26 April 2010).
    • (2004) Latest news
  • 10
    • 0033545523 scopus 로고    scopus 로고
    • Managing psychosis in patients with Parkinson's disease
    • Cummings, J.L. ( 1999) Managing psychosis in patients with Parkinson's disease. N Engl J Med 340: 801-803.
    • (1999) N Engl J Med , vol.340 , pp. 801-803
    • Cummings, J.L.1
  • 11
    • 0027985334 scopus 로고
    • The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia
    • Cummings, J.L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D.A. and Gornbein, J. ( 1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314.
    • (1994) Neurology , vol.44 , pp. 2308-2314
    • Cummings, J.L.1    Mega, M.2    Gray, K.3    Rosenberg-Thompson, S.4    Carusi, D.A.5    Gornbein, J.6
  • 13
    • 0001505068 scopus 로고    scopus 로고
    • Seroquel” treatment of psychosis in parkinsonism [abstract]
    • Evatt, M.L., Jewart, D. and Juncos, J.L. ( 1996) “Seroquel” treatment of psychosis in parkinsonism [abstract]. Mov Disord 11: 595.
    • (1996) Mov Disord , vol.11 , pp. 595
    • Evatt, M.L.1    Jewart, D.2    Juncos, J.L.3
  • 14
    • 0036460857 scopus 로고    scopus 로고
    • Risperidone and Parkinson's disease
    • Factor, S.A., Molho, E.S. and Friedman, J.H. ( 2002) Risperidone and Parkinson's disease. Mov Disord 17: 221-222.
    • (2002) Mov Disord , vol.17 , pp. 221-222
    • Factor, S.A.1    Molho, E.S.2    Friedman, J.H.3
  • 15
    • 0000224448 scopus 로고
    • Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale”
    • Fahn, S., Marsden, C.D., Calne, D.B. and Goldstein, M. (eds) (1987). “Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale”, Recent Developments Parkinson's Dis, 11: pp. 153-163.
    • (1987) Recent Developments Parkinson's Dis , vol.11 , pp. S.-163
    • Fahn1    Marsden, C.D.2    Calne, D.B.3    Goldstein, M.4
  • 16
    • 74149083011 scopus 로고    scopus 로고
    • (2010) Epidemiology of psychosis in Parkinson's disease
    • Fenelon, G. and Alves, G. (2010) Epidemiology of psychosis in Parkinson's disease. J Neurol Sci 289: 12-17.
    • J Neurol Sci , vol.289 , pp. 12-17
    • Fenelon, G.1    Alves, G.2
  • 17
    • 0033453264 scopus 로고    scopus 로고
    • Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
    • Fernandez, H.H., Friedman, J.H., Jacques, C. and Rosenfeld, M. ( 1999) Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 14: 484-487.
    • (1999) Mov Disord , vol.14 , pp. 484-487
    • Fernandez, H.H.1    Friedman, J.H.2    Jacques, C.3    Rosenfeld, M.4
  • 18
    • 70450214108 scopus 로고    scopus 로고
    • (2009) Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study
    • Fernandez, H.H., Okun, M.S., Rodriguez, R.L., Malaty, I.A., Romrell, J., Sun, A. et al. (2009) Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study. Int J Neurosci 119: 2196-2205.
    • Int J Neurosci , vol.119 , pp. 2196-2205
    • Fernandez, H.H.1    Okun, M.S.2    Rodriguez, R.L.3    Malaty, I.A.4    Romrell, J.5    Sun, A.6
  • 19
    • 0038485957 scopus 로고    scopus 로고
    • Long-term outcome of quetiapine use for psychosis among Parkinsonian patients
    • Fernandez, H.H., Trieschmann, M.E., Burke, M.A., Jacques, C. and Friedman, J.H. ( 2003) Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Mov Disord 18: 510-514.
    • (2003) Mov Disord , vol.18 , pp. 510-514
    • Fernandez, H.H.1    Trieschmann, M.E.2    Burke, M.A.3    Jacques, C.4    Friedman, J.H.5
  • 20
    • 0033549287 scopus 로고    scopus 로고
    • Clozapine in drug-induced psychosis in Parkinson's disease
    • French Clozapine Parkinson Study Group
    • French Clozapine Parkinson Study Group (1999 ) Clozapine in drug-induced psychosis in Parkinson's disease. Lancet 353: 2041.
    • (1999) Lancet , vol.353 , pp. 2041
  • 21
    • 0031753772 scopus 로고    scopus 로고
    • Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease
    • Friedberg, G., Zoldan, J., Weizman, A. and Melamed, E. ( 1998) Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 21: 280-284.
    • (1998) Clin Neuropharmacol , vol.21 , pp. 280-284
    • Friedberg, G.1    Zoldan, J.2    Weizman, A.3    Melamed, E.4
  • 22
    • 33846447413 scopus 로고    scopus 로고
    • Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
    • Friedman, J.H., Berman, R.M., Goetz, C.G., Factor, S.A., Ondo, W.G., Wojcieszek, J. et al. (2006) Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord 21: 2078-2208.
    • (2006) Mov Disord , vol.21 , pp. 2078-2208
    • Friedman, J.H.1    Berman, R.M.2    Goetz, C.G.3    Factor, S.A.4    Ondo, W.G.5    Wojcieszek, J.6
  • 23
    • 0034107042 scopus 로고    scopus 로고
    • Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
    • Friedman, J.H. and Factor, S.A. ( 2000) Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 15: 201-211.
    • (2000) Mov Disord , vol.15 , pp. 201-211
    • Friedman, J.H.1    Factor, S.A.2
  • 24
    • 0037366161 scopus 로고    scopus 로고
    • [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease]
    • Gimenez-Roldan, S., Navarro, E. and Mateo, D. ( 2003) [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease]. Rev Neurol 36: 401-404.
    • (2003) Rev Neurol , vol.36 , pp. 401-404
    • Gimenez-Roldan, S.1    Navarro, E.2    Mateo, D.3
  • 25
    • 0035846632 scopus 로고    scopus 로고
    • Prospective longitudinal assessment of hallucinations in Parkinson's disease
    • Goetz, C.G., Leurgans, S., Pappert, E.J., Raman, R. and Stemer, A.B. ( 2001) Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 57: 2078-2082.
    • (2001) Neurology , vol.57 , pp. 2078-2082
    • Goetz, C.G.1    Leurgans, S.2    Pappert, E.J.3    Raman, R.4    Stemer, A.B.5
  • 26
    • 0028901771 scopus 로고
    • Mortality and hallucinations in nursing home patients with advanced Parkinson's disease
    • Goetz, C.G. and Stebbins, G.T. ( 1995) Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 45: 669-671.
    • (1995) Neurology , vol.45 , pp. 669-671
    • Goetz, C.G.1    Stebbins, G.T.2
  • 28
    • 0001179622 scopus 로고    scopus 로고
    • Quetiapine improves psychotic symptoms associated with Parkinson's disease
    • Suppl.
    • Juncos, J.L., Arvanitis, L., Yeung, P., Jewart, R.D. and Nemeroff, C. ( 1999) Quetiapine improves psychotic symptoms associated with Parkinson's disease. Neurology 52(6 Suppl. 2): A262.
    • (1999) Neurology , vol.52 , Issue.6 , pp. A262
    • Juncos, J.L.1    Arvanitis, L.2    Yeung, P.3    Jewart, R.D.4    Nemeroff, C.5
  • 30
    • 0028331326 scopus 로고
    • The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research
    • Kerwin, R.W. ( 1994) The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. Br J Psychiatry 164: 141-148.
    • (1994) Br J Psychiatry , vol.164 , pp. 141-148
    • Kerwin, R.W.1
  • 31
    • 34247487794 scopus 로고    scopus 로고
    • Quetiapine for agitation or psychosis in patients with dementia and Parkinsonism
    • Kurlan, R., Cummings, J., Raman, R. and Thal, L. ( 2007) Quetiapine for agitation or psychosis in patients with dementia and Parkinsonism. Neurology 68: 1356-1363.
    • (2007) Neurology , vol.68 , pp. 1356-1363
    • Kurlan, R.1    Cummings, J.2    Raman, R.3    Thal, L.4
  • 32
    • 1442300046 scopus 로고    scopus 로고
    • Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease
    • Mancini, F., Tassorelli, C., Martignoni, E., Moglia, A., Nappi, G., Cristina, S. et al. (2004) Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. Clin Neuropharmacol 27: 33-37.
    • (2004) Clin Neuropharmacol , vol.27 , pp. 33-37
    • Mancini, F.1    Tassorelli, C.2    Martignoni, E.3    Moglia, A.4    Nappi, G.5    Cristina, S.6
  • 33
    • 33750910746 scopus 로고    scopus 로고
    • Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis
    • Merims, D., Balas, M., Peretz, C., Shabtai, H. and Giladi, N. ( 2006) Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin Neuropharmacol 29: 331-337.
    • (2006) Clin Neuropharmacol , vol.29 , pp. 331-337
    • Merims, D.1    Balas, M.2    Peretz, C.3    Shabtai, H.4    Giladi, N.5
  • 34
    • 53949112680 scopus 로고    scopus 로고
    • Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial
    • Miller, D.D., Caroff, S.N., Davis, S.M., Rosenheck, R.A., McEvoy, J.P., Saltz, B.L. et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial. Br J Psychiatry 193: 279-288.
    • Br J Psychiatry , vol.193 , pp. 279-288
    • Miller, D.D.1    Caroff, S.N.2    Davis, S.M.3    Rosenheck, R.A.4    McEvoy, J.P.5    Saltz, B.L.6
  • 35
    • 33646107153 scopus 로고    scopus 로고
    • Quality Standards Subcommittee of the American Academy of Neurology Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
    • Miyasaki, J.M., Shannon, K., Voon, V., Ravina, B., Kleiner-Fisman, G. and Anderson, K. Quality Standards Subcommittee of the American Academy of Neurology Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66: 996-1002.
    • Neurology , vol.66 , pp. 996-1002
    • Miyasaki, J.M.1    Shannon, K.2    Voon, V.3    Ravina, B.4    Kleiner-Fisman, G.5    Anderson, K.6
  • 38
    • 0036764866 scopus 로고    scopus 로고
    • Olanzapine treatment for dopaminergic-induced hallucinations
    • Ondo, W.G., Levy, J.K., Vuong, K.D., Hunter, C. and Jankovic, J. ( 2002) Olanzapine treatment for dopaminergic-induced hallucinations. Mov Disord 17: 1031-1035.
    • (2002) Mov Disord , vol.17 , pp. 1031-1035
    • Ondo, W.G.1    Levy, J.K.2    Vuong, K.D.3    Hunter, C.4    Jankovic, J.5
  • 39
    • 26444597010 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
    • Ondo, W.G., Tintner, R., Voung, K.D., Lai, D. and Ringholz, G. ( 2005) Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Mov Disord 20: 958-963.
    • (2005) Mov Disord , vol.20 , pp. 958-963
    • Ondo, W.G.1    Tintner, R.2    Voung, K.D.3    Lai, D.4    Ringholz, G.5
  • 40
    • 0002164061 scopus 로고
    • ECDEU Assessment Manual for Psychopharmacology (Revised Edition) Rockville, MD: USNIH, Psychopharmacology Research Branch
    • Overall, J. and Gorham, D. ( 1976) Brief psychiatric rating scale (BPRS) 1962, In: Guy, W. (ed.). ECDEU Assessment Manual for Psychopharmacology (Revised Edition), Rockville, MD : USNIH, Psychopharmacology Research Branch, pp. 158-169.
    • (1976) Brief psychiatric rating scale (BPRS) 1962 , pp. 158-169
    • Overall, J.1    Gorham, D.2    Guy, W.3
  • 41
    • 0033545542 scopus 로고    scopus 로고
    • Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease
    • Parkinson Study Group
    • Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 340: 757-763.
    • (1999) N Engl J Med , vol.340 , pp. 757-763
  • 42
    • 0034684139 scopus 로고    scopus 로고
    • Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial
    • Parkinson Study Group
    • Parkinson Study Group (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. JAMA 284: 1931-1938.
    • (2000) JAMA , vol.284 , pp. 1931-1938
  • 43
    • 32844465773 scopus 로고    scopus 로고
    • The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview
    • Prohorov, T., Klein, C., Miniovitz, A., Dobronevsky, E. and Rabey, J.M. ( 2006) The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview. J Neurol 253: 171-175.
    • (2006) J Neurol , vol.253 , pp. 171-175
    • Prohorov, T.1    Klein, C.2    Miniovitz, A.3    Dobronevsky, E.4    Rabey, J.M.5
  • 44
    • 34147140466 scopus 로고    scopus 로고
    • Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months’ duration
    • Rabey, J.M., Prokhorov, T., Miniovitz, A., Dobronevsky, E. and Klein, C. ( 2007) Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months’ duration. Mov Disord 22: 313-318.
    • (2007) Mov Disord , vol.22 , pp. 313-318
    • Rabey, J.M.1    Prokhorov, T.2    Miniovitz, A.3    Dobronevsky, E.4    Klein, C.5
  • 45
    • 0034682308 scopus 로고    scopus 로고
    • A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group
    • Rascol, O., Brooks, D.J., Korczyn, A.D., de Deyn, P.P., Clarke, C.E. and Lang, A.E. ( 2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 342: 1484-1491.
    • (2000) N Engl J Med , vol.342 , pp. 1484-1491
    • Rascol, O.1    Brooks, D.J.2    Korczyn, A.D.3    de Deyn, P.P.4    Clarke, C.E.5    Lang, A.E.6
  • 46
    • 0036652714 scopus 로고    scopus 로고
    • The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia
    • Reddy, S., Factor, S.A., Molho, E.S. and Feustel, P.J. ( 2002) The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Mov Disord 17: 676-681.
    • (2002) Mov Disord , vol.17 , pp. 676-681
    • Reddy, S.1    Factor, S.A.2    Molho, E.S.3    Feustel, P.J.4
  • 47
    • 26844538114 scopus 로고    scopus 로고
    • Risk of death with atypical antipsychotic drug treatment for dementia. Meta-analysis of randomized placebo-controlled trials
    • Schneider, L.S., Dagerman, K.S. and Insel, P. ( 2005) Risk of death with atypical antipsychotic drug treatment for dementia. Meta-analysis of randomized placebo-controlled trials. JAMA 294: 1934-1943.
    • (2005) JAMA , vol.294 , pp. 1934-1943
    • Schneider, L.S.1    Dagerman, K.S.2    Insel, P.3
  • 48
    • 70449698819 scopus 로고    scopus 로고
    • (2009) A randomized controlled trial of quetiapine for psychosis in Parkinson's disease
    • Shotbolt, P., Samuel, M., Fox, C. and David, A.S. (2009) A randomized controlled trial of quetiapine for psychosis in Parkinson's disease. Neuropsychiatr Dis Treat 5: 327-332.
    • Neuropsychiatr Dis Treat , vol.5 , pp. 327-332
    • Shotbolt, P.1    Samuel, M.2    Fox, C.3    David, A.S.4
  • 51
    • 0033955214 scopus 로고    scopus 로고
    • Efficacy of quetiapine in Parkinson's patients with psychosis
    • Targum, S.D. and Abbott, J.L. ( 2000) Efficacy of quetiapine in Parkinson's patients with psychosis. J Clin Psychopharmacol 20: 54-60.
    • (2000) J Clin Psychopharmacol , vol.20 , pp. 54-60
    • Targum, S.D.1    Abbott, J.L.2
  • 52
    • 0034901147 scopus 로고    scopus 로고
    • Management of psychosis in Parkinson's disease
    • Wolters, E.C. and Berendse, H.W. ( 2001) Management of psychosis in Parkinson's disease. Curr Opin Neurol 14: 499-504.
    • (2001) Curr Opin Neurol , vol.14 , pp. 499-504
    • Wolters, E.C.1    Berendse, H.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.